Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | Biomarkers in Alzheimer’s disease

Kejal Kantarci, MD from the Mayo Clinic, Rochester, MN gives an overview on Alzheimer’s disease biomarkers at the Alzheimer’s Association International Conference (AAIC) 2017, London, UK. Dr Kantarci feels that more work needs to be done around alpha-synuclein including identification, ligand binding and CSF biomarkers. She also explains how the MRI field is increasingly being used to identify physical biomarkers that are linked to pathology relevant to clinical disease syndromes.

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.